ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
66,168.99
-0.03%
S&P 500
5,431.60
-0.04%
Dow Jones
38,589.16
-0.15%
US Dollar vs Yen
157.405
0.00%
Brent Oil
82.275
0.00%
Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Fulcrum Therapeutics Inc (FULC)

  7. Fulcrum Therapeutics Inc (FULC) ニュース

FULC

Fulcrum Therapeutics (FULC)

Fulcrum Therapeutics Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:FULC
日付受信時刻ニュースソース見出しコード企業名
2024/05/1320 : 15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FULCFulcrum Therapeutics Inc
2024/05/1320 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FULCFulcrum Therapeutics Inc
2024/05/1005 : 10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FULCFulcrum Therapeutics Inc
2024/03/0908 : 05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FULCFulcrum Therapeutics Inc
2024/03/0908 : 00Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:FULCFulcrum Therapeutics Inc
2024/03/0606 : 15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FULCFulcrum Therapeutics Inc
2024/02/2807 : 18Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:FULCFulcrum Therapeutics Inc
2024/02/2807 : 12Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:FULCFulcrum Therapeutics Inc
2024/02/2806 : 01Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:FULCFulcrum Therapeutics Inc
2024/02/2721 : 01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FULCFulcrum Therapeutics Inc
2024/01/3111 : 10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FULCFulcrum Therapeutics Inc
2024/01/3111 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FULCFulcrum Therapeutics Inc
2023/11/0721 : 05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FULCFulcrum Therapeutics Inc
2023/11/0721 : 02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FULCFulcrum Therapeutics Inc
2023/10/0305 : 01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FULCFulcrum Therapeutics Inc
2023/08/2220 : 48Dow Jones NewsFulcrum Therapeutics Shares Rally Premarket as FDA Lifts Study HoldNASDAQ:FULCFulcrum Therapeutics Inc
2023/08/2220 : 01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FULCFulcrum Therapeutics Inc
2023/08/1205 : 53GlobeNewswire Inc.Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:FULCFulcrum Therapeutics Inc
2023/08/0320 : 11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FULCFulcrum Therapeutics Inc
2023/08/0320 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FULCFulcrum Therapeutics Inc
2023/07/1106 : 06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FULCFulcrum Therapeutics Inc
2023/07/0806 : 30GlobeNewswire Inc.Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:FULCFulcrum Therapeutics Inc
2023/07/0405 : 16Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:FULCFulcrum Therapeutics Inc
2023/06/3005 : 24Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FULCFulcrum Therapeutics Inc
2023/06/3005 : 17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FULCFulcrum Therapeutics Inc
2023/06/3005 : 17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FULCFulcrum Therapeutics Inc
2023/06/3005 : 17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FULCFulcrum Therapeutics Inc
2023/06/3005 : 16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FULCFulcrum Therapeutics Inc
2023/06/3005 : 16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FULCFulcrum Therapeutics Inc
2023/06/3005 : 16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FULCFulcrum Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:FULC

最近閲覧した銘柄

ASX
IOGNA
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有